IL-6 Trans-Signaling in the Brain Influences the Metabolic Phenotype of the 3xTg-AD Mouse Model of Alzheimer’s Disease
Authors:
- Anna EscrigAEAnna Escrig
- Amalia MolineroAMAmalia Molinero
- Brenda MéndezBMBrenda Méndez
- Mercedes GiraltMGMercedes Giralt
- Gemma ComesGCGemma Comes
- Paula SanchisPSPaula Sanchis
- Olaya Fernández-GayolOFOlaya Fernández-Gayol
- Lydia Giménez-LlortLydia Giménez-Llort
- Christoph Becker-PaulyCBChristoph Becker-Pauly
- Stefan Rose-JohnSRStefan Rose-John
- Juan HidalgoJHJuan Hidalgo
Open Access
Abstract
Alzheimer’s disease (AD) is a neurodegenerative disorder that causes the most prevalent dementia in the elderly people. Obesity and insulin resistance, which may cause major health problems per se, are risk factors for AD, and cytokines such as interleukin-6 (IL-6) have a role in these conditions. IL-6 can signal either through a membrane receptor or by trans-signaling, which can be inhibited by the soluble form of the co-receptor gp130 (sgp130). We have addressed the possibility that blocking IL-6 trans-signaling in the brain could have an effect in the triple transgenic 3xTg-AD mouse model of AD and/or in obesity progression, by crossing 3xTg-AD mice with GFAP-sgp130Fc mice. To serve as control groups, GFAP-sgp130Fc mice were also crossed with C57BL/6JOlaHsd mice. Seventeen-month-old mice were fed a control diet (18% kcal from fat) and a high-fat diet (HFD; 58.4% kcal from fat). In our experimental conditions, the 3xTg-AD model showed a mild amyloid phenotype, which nevertheless altered the control of body weight and related endocrine and metabolic factors, suggestive of a hypermetabolic state. The inhibition of IL-6 trans-signaling modulated some of these traits in both 3xTg-AD and control mice, particularly during HFD, and in a sex-dependent manner. These experiments provide evidence of IL-6 trans-signaling playing a role in the CNS of a mouse model of AD.Keywords
Funding Information
- Ministerio de Economía y Competitividad (SAF2014-56546-R, RTI2018-101105-B-I00)
- Fundació la Marató de TV3 (20142210)
- European Regional Development Fund (SAF2014-56546-R, RTI2018-101105-B-I00)
- Deutsche Forschungsgemeinschaft (CRC877, SFB877)
This publication has 59 references indexed in Scilit:
- Sex-Specific Effects of High Fat Diet on Indices of Metabolic Syndrome in 3xTg-AD Mice: Implications for Alzheimer's DiseasePLOS ONE, 2013
- A general and simple method for obtaining R2 from generalized linear mixed‐effects modelsMethods in Ecology and Evolution, 2012
- Impaired Satiation and Increased Feeding Behaviour in the Triple-Transgenic Alzheimer's Disease Mouse ModelPLOS ONE, 2012
- Interleukin-6, a Major Cytokine in the Central Nervous SystemInternational Journal of Biological Sciences, 2012
- Mouse genomic variation and its effect on phenotypes and gene regulationNature, 2011
- Amyloid-β and tau — a toxic pas de deux in Alzheimer's diseaseNature Reviews Neuroscience, 2010
- Human IL6 enhances leptin action in miceDiabetologia, 2009
- Interleukin‐6 Gene Knockout Influences Energy Balance Regulating Peptides in the Hypothalamic Paraventricular and Supraoptic NucleiJournal of Neuroendocrinology, 2009
- Detailed immunohistochemical characterization of temporal and spatial progression of Alzheimer's disease-related pathologies in male triple-transgenic miceBMC Neuroscience, 2008
- Intraneuronal Aβ Causes the Onset of Early Alzheimer’s Disease-Related Cognitive Deficits in Transgenic MiceNeuron, 2005